ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 125 participants.
Also called NCT06167213
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 125 participants
- Sponsor
- Registry
-
NCT06167213
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06167213. Non-randomized; no masking; primary purpose treatment. Start 2027-01 (anticipated); primary completion 2029-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral
- Condition
- Mitral Regurgitation
- Condition
- Mitral Valve Disease
- Condition
- Mitral Stenosis
- Intervention (Device)
- SAPIEN X4 THV
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct06167213- Content hash
f1814ac978613d796a669136741949a26cf8da026988b36960df2143548577dd